medigraphic.com

2018, Number S1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2018; 56 (S1)

Flavonoids in the treatment of hypertension in geriatric patients

Gutiérrez-Venegas G

Language: Spanish
References: 22
Page: 94-101
PDF size: 316.68 Kb.


ABSTRACT

Background: Geriatric patients belong to a group over 65 years old. In general these patients present multiple chronic diseases and impairments with disability, body mass diminished and generalized fatigue. On the other hand, a high percentage of these patients have cardiovascular diseases. For this reason, several studies suggest that associated with drugs treatment consumption of natural products such as flavonoids, contribute to improve the quality of life of geriatric patients. The aim of this work is to review in literature the effect of flavonoids in vascular protection of older adults.
Results: Literature review indicates that the intake of flavonoids significantly reduces the risk of hypertension and cardiovascular disease. Likewise, its consumption is associated with an improvement in endothelial function, since they act regulating different kinases like protein kinase B, nitric oxide synthase and the consequent synthesis of nitric oxide (NO), which leads to improve vasodilation. Finally, flavonoids also act to regulate the functioning of other kinases, phophodiesterases, ion channels diminishing vascular inflammation.
Conclusion: Foods enriched in polyphenols improve endothelial function by promoting vascular dilation and lowering blood pressure.


REFERENCES

  1. Aitken M, Kleinrock M, Lyle J, Caskey L. Medicine use and the shifting cost of healthcare. A Review of the Use of Medicines in the United States in 2013. Parsippany, NJ: IMS Health, 2014.

  2. Agati G, Azzarello E, Pollastri S, Tattini M. Flavonoids as antioxidants in plants: location and functional significance. Plant Sci. 2012;196:67-76. doi: 10.1016/j.plantsci.2012.07.014.

  3. Stuper-Szablewska K, Perkowski J. Phenolic acids in cereal grain: Occurrence, biosynthesis, metabolism and role in living organisms. Crit Rev Food Sci Nutr. 2017 Oct 4:1-12. doi: 10.1080/10408398.2017.1387096.

  4. Nomoto Y, Harinantenaina I, Sugimoto S, Matsunami K, Otsuka H. c-Glycosil flavonoids and colaratane-type sesquiterpen glucosides from the water-solubre fraction of a leaf extract of a Malagasy endemic plant, Cinnamosma fragrans (Canellaceae). J Nat Med. 2013;67(4):736-42. doi: 10.1007/ s11418-012-0736-x.

  5. Galleano M, Pechanova O, Fraga CG. Hypertension, nitric oxide, oxidants, and dietary plant polyphenols. Curr Pharm Biotechnol. 2010 Dec;11(8):837-48.

  6. Takami S, Imai T, Hasumura M, Cho YM, Onose J, Hirose M. Evaluation of toxicity of green tea catechins with 90-day dietary administration to F344 rats. Food Chem Toxicol. 2008 Jun;46(6):2224-9. doi: 10.1016/j.fct.2008.02.023.

  7. Zheng W, Wang SY. Antioxidant activity and phenolic compounds in selected herbs. J Agric Food Chem. 2001 Nov;49(11):5165-70.

  8. Testai L, Calderone V. Nutraceutical Value of Citrus Flavanones and Their Implications in Cardiovascular Disease. Nutrients. 2017 May 16;9(5). pii: E502. doi: 10.3390/nu9050502.

  9. Steffen Y, Gruber C, Schewe T, Sies H. Mono-Omethylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys. 2008 Jan 15;469(2):209-19.

  10. Grassi D, Mulder TP, Draijer R, Desideri G, Molhuizen HO, Ferri C. Black tea comsumption dosedepently improves flow-mediated dilathion in healty males. J Hypertens. 2009 Apr;27(4):774-81. doi: 10.1097/HJH.0b013e328326066c.

  11. San Cheang W, Yuen Ngai C, Yen Tam Y, Yu Tian X, Tak Wong W, Zhang Y, et al. Black tea protects against hypertension-associated endothelial dysfunction through alleviation of endoplasmic reticulum stress. Sci Rep. 2015 May 15;5:10340. doi: 10.1038/srep10340. Texto libre en https://www.ncbi. nlm.nih.gov/pmc/articles/PMC4432571/

  12. Anter E, Chen K, Shapira OM, Karas RH, Keaney JF Jr. p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor alpha-dependent pathway in response to black tea polyphenols. Circ Res. 2005 May 27;96(10):1072-8.

  13. Follmann M1, Griebenow N, Hahn MG, Hartung I, Mais FJ, Mittendorf J, et al. The chemistry and biology of soluble guanylate cyclase stimulators and activators. Angew Chem Int Ed Engl. 2013 Sep 2;52 (36):9442-62. doi: 10.1002/anie.201302588.

  14. Keske MA, Ng HL, Premilovac D, Rattigan S, Kim JA, Munir K, et al. Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate. Curr Med Chem. 2015;22(1):59-69. Texto libre en https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC4909506/

  15. Frankel EN, Waterhouse AL, Teissedre PL. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J Agric Food Chem. 1995;43:890-4.

  16. Ferreira D, Slade S. Oligomeric proanthocyanidins: Naturally-occurring O-heterocycles. Nat Prod Rep. 2002;19:517-41.

  17. Ferreira D, Li XC. Oligomeric proanthocyanidins: Naturally-occurring O-heterocycles. Nat Prod Rep. 2000;17:193-212.

  18. Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea--a review. J Am Coll Nutr. 2006;25:79-99.

  19. Wolfram S, Wang Y, Thielecke F. Anti-obesity effects of green tea: from bedside to bench. Mol Nutr Food Res. 2006;50:176-87.

  20. Kao YH, Chang HH, Lee MJ, Chen CL. Tea, obesity, and diabetes. Mol Nutr Food Res. 2006;50:188-210.

  21. Yoshimoto T, Furukawa M, Yamamoto S, Horie T, Watanabe-Kohno S. Flavonoids: Potent inhibitors of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun. 1983;116:612-8.

  22. Vera R, Sánchez M, Galisteo M, Villar IC, Jimenez R, Zarzuelo A, et al. Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity. Clin Sci (Lond). 2007;112:183-91.




2020     |     www.medigraphic.com